Erika Söderberg Johnson leaves Biotage

Contact person:
Torben Jörgensen, CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com
 

Erika Söderberg Johnson has today informed Biotage that she, after eight years of employment, is leaving the position as CFO. Erika Söderberg Johnson has a six months notice period. The company will now initiate the recruitment of a successor.
 

This information was submitted for publication, through the agency of the contact persons set out above, at 07:30 CET on October 1, 2019.
 

About Biotage
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, contract research and contract manufacturing companies, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 440 employees and had sales of 911 MSEK in 2018. Biotage is listed on NASDAQ Stockholm. Website: www.biotage.com

Tags:

About Us

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in Drug Discovery and Development, Analytical Testing and Water and Environmental Testing. Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.Our customers span a broad range of market segments including Pharmaceutical, Biotech, Contract Research and Contract Manufacturers as well as Clinical, Forensic and Academic laboratories in addition to organizations focused on Food safety, Clean water and Environmental sustainability. Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of SEK 1,092 million in 2020 and our products are sold in more than 70 countries. Biotage share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.Website: www.biotage.com

Subscribe

Documents & Links